| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |